BIOMAT Database Logo BIOMAT Database Logo

Expression of HLA class I-encoded cell surface antigens in transitional cell carcinoma of the urinary bladder. 1992

I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
Department of Urology, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.

UI MeSH Term Description Entries
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005805 Genes, MHC Class I Genetic loci in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., B loci (chicken), DLA (dog), GPLA (guinea pig), H-2 (mouse), RT-1 (rat), HLA-A, -B, and -C class I genes of man. Class I Genes,Genes, Class I,Genes, H-2 Class I,Genes, HLA Class I,MHC Class I Genes,H-2 Class I Genes,HLA Class I Genes,Class I Gene,Gene, Class I,Genes, H 2 Class I,H 2 Class I Genes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte

Related Publications

I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
HLA antigens and transitional cell carcinoma of the bladder.
January 1990, Urologia internationalis,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
HLA-A and HLA-B antigens in transitional cell carcinoma of the bladder.
October 1979, The Journal of urology,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
Class I and class II HLA antigen expression by transitional cell carcinoma of the bladder: correlation with T-cell infiltration and BCG treatment.
June 1989, The Journal of urology,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
[Expression of HLA-class I and II antigens on basal cell carcinoma].
December 1990, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
HLA class I and II antigens expression in patients with renal cell carcinoma.
January 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
December 1999, Journal of experimental & clinical cancer research : CR,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
July 1990, Journal of clinical pathology,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
February 2000, The American journal of pathology,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
August 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
I Levin, and B Klein, and S Segal, and A Eyal, and J Gopas, and J Kaneti, and M Saadon, and O Kuperman
c-jun oncogene expression in transitional cell carcinoma of the urinary bladder.
December 1994, British journal of urology,
Copied contents to your clipboard!